Business Description
Entheon Biomedical Corp
NAICS : 325412
SIC : 3741
ISIN : CA29383X1033
Share Class Description:
STU:1XU: Ordinary SharesCompare
Compare
Traded in other countries / regions
ENBI.Canada1XU.GermanyENTBF.USA IPO Date
2020-12-09Description
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 39.8 | |||||
| 3-Year EPS without NRI Growth Rate | 40.3 | |||||
| 3-Year FCF Growth Rate | 41.8 | |||||
| 3-Year Book Growth Rate | -73.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.23 | |||||
| 9-Day RSI | 61.86 | |||||
| 14-Day RSI | 60.23 | |||||
| 6-1 Month Momentum % | -26.2 | |||||
| 12-1 Month Momentum % | 56.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | |||||
| Quick Ratio | 12.2 | |||||
| Cash Ratio | 11.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -113.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -124.26 | |||||
| ROE % | -105.17 | |||||
| ROA % | -90.46 | |||||
| ROIC % | -5383.33 | |||||
| ROCE % | -110.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.33 | |||||
| PB Ratio | 5.38 | |||||
| Price-to-Tangible-Book | 4.6 | |||||
| EV-to-EBIT | -3.13 | |||||
| EV-to-EBITDA | -3.13 | |||||
| EV-to-Revenue | 4.06 | |||||
| EV-to-FCF | -3.25 | |||||
| Price-to-Net-Current-Asset-Value | 4.6 | |||||
| Price-to-Net-Cash | 9.2 | |||||
| Earnings Yield (Greenblatt) % | -31.9 | |||||
| FCF Yield % | -25.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entheon Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.169 | ||
| EPS (TTM) (€) | -0.026 | ||
| Beta | 1.16 | ||
| Volatility % | 153.75 | ||
| 14-Day RSI | 60.23 | ||
| 14-Day ATR (€) | 0.009581 | ||
| 20-Day SMA (€) | 0.083325 | ||
| 12-1 Month Momentum % | 56.82 | ||
| 52-Week Range (€) | 0.01 - 0.1448 | ||
| Shares Outstanding (Mil) | 8.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Entheon Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Entheon Biomedical Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Entheon Biomedical Corp Frequently Asked Questions
What is Entheon Biomedical Corp(STU:1XU)'s stock price today?
The current price of STU:1XU is €0.09. The 52 week high of STU:1XU is €0.14 and 52 week low is €0.01.
When is next earnings date of Entheon Biomedical Corp(STU:1XU)?
The next earnings date of Entheon Biomedical Corp(STU:1XU) is .
Does Entheon Biomedical Corp(STU:1XU) pay dividends? If so, how much?
Entheon Biomedical Corp(STU:1XU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers